Open Access
Open access
том 37 издание 1 страницы 527-530

Replacing the phthalimide core in thalidomide with benzotriazole

Тип публикацииJournal Article
Дата публикации2022-02-28
scimago Q2
wos Q1
БС1
SJR0.857
CiteScore11.2
Impact factor5.4
ISSN14756366, 14756374
Drug Discovery
General Medicine
Pharmacology
Краткое описание
Abstract The advent of proteolysis-targeting chimaeras (PROTACs) mandates that new ligands for the recruitment of E3 ligases are discovered. The traditional immunomodulatory drugs (IMiDs) such as thalidomide and its analogues (all based on the phthalimide glutarimide core) bind to Cereblon, the substrate receptor of the CRL4ACRBN E3 ligase. We designed a thalidomide analogue in which the phthalimide moiety was replaced with benzotriazole, using an innovative synthesis strategy. Compared to thalidomide, the resulting “benzotriazolo thalidomide” has a similar binding mode, but improved properties, as revealed in crystallographic analyses, affinity assays and cell culture.
Найдено 
Найдено 

Топ-30

Журналы

1
2
3
European Journal of Medicinal Chemistry
3 публикации, 21.43%
Mendeleev Communications
3 публикации, 21.43%
Biochemical and Biophysical Research Communications
2 публикации, 14.29%
Journal of Medicinal Chemistry
2 публикации, 14.29%
SSRN Electronic Journal
1 публикация, 7.14%
Beilstein Journal of Organic Chemistry
1 публикация, 7.14%
Journal of Organic Chemistry
1 публикация, 7.14%
RSC Medicinal Chemistry
1 публикация, 7.14%
1
2
3

Издатели

1
2
3
4
5
Elsevier
5 публикаций, 35.71%
OOO Zhurnal "Mendeleevskie Soobshcheniya"
3 публикации, 21.43%
American Chemical Society (ACS)
3 публикации, 21.43%
Social Science Electronic Publishing
1 публикация, 7.14%
Beilstein-Institut
1 публикация, 7.14%
Royal Society of Chemistry (RSC)
1 публикация, 7.14%
1
2
3
4
5
  • Мы не учитываем публикации, у которых нет DOI.
  • Статистика публикаций обновляется еженедельно.

Вы ученый?

Создайте профиль, чтобы получать персональные рекомендации коллег, конференций и новых статей.
Метрики
14
Поделиться
Цитировать
ГОСТ |
Цитировать
Krasavin M. et al. Replacing the phthalimide core in thalidomide with benzotriazole // Journal of Enzyme Inhibition and Medicinal Chemistry. 2022. Vol. 37. No. 1. pp. 527-530.
ГОСТ со всеми авторами (до 50) Скопировать
Krasavin M., Bubyrev A., Kazantsev A., Heim C., Maiwald S., Zhukovsky D., Darin D., Hartmann M. D., Bunev A. Replacing the phthalimide core in thalidomide with benzotriazole // Journal of Enzyme Inhibition and Medicinal Chemistry. 2022. Vol. 37. No. 1. pp. 527-530.
RIS |
Цитировать
TY - JOUR
DO - 10.1080/14756366.2021.2024525
UR - https://doi.org/10.1080/14756366.2021.2024525
TI - Replacing the phthalimide core in thalidomide with benzotriazole
T2 - Journal of Enzyme Inhibition and Medicinal Chemistry
AU - Krasavin, Mikhail
AU - Bubyrev, Andrey
AU - Kazantsev, Alexander
AU - Heim, Christopher
AU - Maiwald, Samuel
AU - Zhukovsky, Daniil
AU - Darin, Dmitry
AU - Hartmann, Marcus D.
AU - Bunev, Alexander
PY - 2022
DA - 2022/02/28
PB - Taylor & Francis
SP - 527-530
IS - 1
VL - 37
PMID - 35220840
SN - 1475-6366
SN - 1475-6374
ER -
BibTex |
Цитировать
BibTex (до 50 авторов) Скопировать
@article{2022_Krasavin,
author = {Mikhail Krasavin and Andrey Bubyrev and Alexander Kazantsev and Christopher Heim and Samuel Maiwald and Daniil Zhukovsky and Dmitry Darin and Marcus D. Hartmann and Alexander Bunev},
title = {Replacing the phthalimide core in thalidomide with benzotriazole},
journal = {Journal of Enzyme Inhibition and Medicinal Chemistry},
year = {2022},
volume = {37},
publisher = {Taylor & Francis},
month = {feb},
url = {https://doi.org/10.1080/14756366.2021.2024525},
number = {1},
pages = {527--530},
doi = {10.1080/14756366.2021.2024525}
}
MLA
Цитировать
Krasavin, Mikhail, et al. “Replacing the phthalimide core in thalidomide with benzotriazole.” Journal of Enzyme Inhibition and Medicinal Chemistry, vol. 37, no. 1, Feb. 2022, pp. 527-530. https://doi.org/10.1080/14756366.2021.2024525.